Supply of Parallel Bioreactor including Maintenance and Consumables

NHS Blood and Transplant is leading a procurement for the provision and maintenance of a Parallel Bioreactor and associated consumables.

We are looking to appoint one (1) Supplier for the provision of this requirement.

The Clinical Biotechnology Centre (CBC) are committed to providing manufacturing capability for viral vector products used in cell and gene therapies. As part of the Medical Research Council funded network for innovation in gene therapies, the CBC anticipate onboarding multiple viral vector projects per year. To reduce the risk of failed batches in GMP manufacturing, the onboarding process, any GMP contracts will be subject to intensive process definition at small scale prior to proceeding with GMP manufacturing contracts.

The required parallel small-scale bioreactor system is critical for the onboarding process in allowing the process development to characterise the operational space (experimental space) and its critical process parameters. A small-scale parallel enables these parameters to be established at reduces scale enabling a larger number of parameters to be established.